95 related articles for article (PubMed ID: 22148937)
1. Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer.
Hayashi S; Oji Y; Kanai Y; Teramoto T; Kitaichi M; Kawaguchi T; Okada M; Sugiyama H; Matsumura A
Cancer Invest; 2012 Feb; 30(2):165-71. PubMed ID: 22148937
[TBL] [Abstract][Full Text] [Related]
2. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
Miyoshi Y; Ando A; Egawa C; Taguchi T; Tamaki Y; Tamaki H; Sugiyama H; Noguchi S
Clin Cancer Res; 2002 May; 8(5):1167-71. PubMed ID: 12006533
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
Takanami I
Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the Wilms' tumor gene WT1 in esophageal cancer.
Oji Y; Yano M; Nakano Y; Abeno S; Nakatsuka S; Ikeba A; Yasuda T; Fujiwara Y; Takiguchi S; Yamamoto H; Fujita S; Kanato K; Ito K; Jomgeow T; Kawakami M; Tsuboi A; Shirakata T; Nishida S; Hosen N; Oka Y; Aozasa K; Monden M; Sugiyama H
Anticancer Res; 2004; 24(5B):3103-8. PubMed ID: 15510596
[TBL] [Abstract][Full Text] [Related]
5. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W
IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740
[TBL] [Abstract][Full Text] [Related]
6. Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers.
Oji Y; Miyoshi S; Takahashi E; Koga S; Nakano Y; Shintani Y; Hirabayashi H; Matsumura A; Iuchi K; Ito K; Kishimoto Y; Tsuboi A; Ikegame K; Hosen N; Oka Y; Ogawa H; Maeda H; Hayashi S; Kawase I; Sugiyama H
Neoplasma; 2004; 51(1):17-20. PubMed ID: 15004653
[TBL] [Abstract][Full Text] [Related]
7. [Expression of ERCC1 mRNA and its impact on the prognosis of patients with non-small cell lung cancer].
Ma W; Li W; Gao M; Li XN
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):371-4. PubMed ID: 21875468
[TBL] [Abstract][Full Text] [Related]
8. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome.
Busse A; Gökbuget N; Siehl JM; Hoelzer D; Schwartz S; Rietz A; Thiel E; Keilholz U
Ann Hematol; 2009 Dec; 88(12):1199-205. PubMed ID: 19404640
[TBL] [Abstract][Full Text] [Related]
10. WT1 promotes invasion of NSCLC via suppression of CDH1.
Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y
J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386
[TBL] [Abstract][Full Text] [Related]
11. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
13. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
14. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
Dai CH; Li J; Shi SB; Yu LC; Ge LP; Chen P
Jpn J Clin Oncol; 2010 Apr; 40(4):327-35. PubMed ID: 20056675
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
[TBL] [Abstract][Full Text] [Related]
16. Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
Feng Y; Wang W; Hu J; Ma J; Zhang Y; Zhang J
Anat Rec (Hoboken); 2010 May; 293(5):802-12. PubMed ID: 20225197
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
[TBL] [Abstract][Full Text] [Related]
19. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer.
Yu M; Wan Y; Zou Q
Clin Biochem; 2008 Jul; 41(10-11):824-30. PubMed ID: 18420035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
